ucsf banner
Helen Diller Family Compr Cancer Ctr
ELIZABETH A. HOLLY, PHD, MPH

Professor, Epidemiology and Biostatistics, UCSF

CONTACT

elizabeth.holly@ucsf.edu
(415) 476-3345 (voice)
(415) 563-4602 (fax)

Box 1228, UCSF; San Francisco, CA 94143-1228

additional websites:

Holly Faculty Profile

EDUCATION

University of California, Berkeley, M.P.H., 1976, Public Health Education
University of California, Berkeley, M.S., 1977, Epidemiology
University of California, Berkeley, Ph.D., 1981, Epidemiology
University of Washington, Seattle, Postdoc, 1981, Case-Control Epidemiology

PROFESSIONAL EXPERIENCE

1977 - 1991

Faculty, Department of Epidemiology and Biostatistics, UCSF

1981 - 1991

Epidemiologist and Assistant Director, Epidemiol., Northern California Cancer Center, Belmont, CA

1986 - present

Consulting Professor, Dept. of Health Research and Policy, Stanford University

1991 - present

Professor, School of Medicine, Dept. of Epidemiology and Biostatistics, UCSF

2001 - 2003

Assoc. Dir., Population Sciences (Interim), UCSF Helen Diller Family Comprehensive Cancer Center

HONORS & AWARDS

1965-66,1966-67

Bissell Award for Outstanding Academic Achievement

1967

Honors graduate (B.A.)

1975-1980

DHEW Public Health Fellowship

1979-1980

Grossman Endowment/NIH Research Award

1984-present

Ad hoc grant and contract review committees, NIH

1981

Post-doc Fellow, NIH Cancer Epidemiology

1987-1991

Epidemiology & Disease Control Study Section II, NIH

1991-2002

American Society of Preventive Oncology Executive Board (elected)

1998-2003

NCI Board of Scientific Counselors, Clinical Sciences and Epidemiology

1999

NCI Environmental Epidemiology Program Review Panel

1999

NCI Concept Review Committee, Costa Rican HPV Vaccine Trial

1999

NCI Viral Epidemiology Program, Chair of Expert Review Panel

1999

NCI Branch Review, Committee for Cancer Epidemiology & Genetics

1999-2000

NCI Committee on Confidentiality of Clinical Research Data

2000

NCI Nutritional Epidemiology Branch, Program Review Co-Chair

1999-2002

Society of Epidemiologic Research, Executive Board (elected)

2000-2003

NCI Epi-Immunology Panel on Non-Hodgkin's Lymphoma

2000-present

NCI Data Safety Monitoring Board, Costa Rican HPV Vaccine Trial

2002-2004

NCI Simian Virus 40 Advisory Board

2002-present

NCI Advisory Committee for Costa Rican HPV Vaccine Trial

2006

Top 5% of scientists in grant-funding awarded by NIH over past 25 years

SELECTED PUBLICATIONS

(selected from 2003-2006)

Holly EA, Bracci PM. Population-based study of non-Hodgkin's lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. AJE 158:316-327, 2003

Holly EA, Eberle C, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay Area. Am J Epidemiol 158:432-441, 2003

Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiology, Biomarkers & Prevention 13:138-143, 2004

Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104:2155-62, 2004

Holly EA, Chaliha I, Bracci PM, Gautam M. Signs and symptoms of pancreatic cancer: A population-based case-control study in the San Francisco Bay Area. Clinical Gastroenterol Hepatol 2:510-17, 2004

Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Coats A, Hegedus C, Smith MT. Body mass index, leptin, and leptin receptor polymorphisms and non-Hodgkin's lymphoma. Cancer Epidemiology, Biomarkers & Prevention 13:779-86, 2004

Duell EJ, Holly EA. Reproductive and menstrual risk factors for pancreatic cancer: A population-based study among San Francisco Bay Area women. Am J Epidemiol 161:741-747, 2005

Morton LM, Hartge P, Holford TR, Holly EA, Chiu BCH, Vineis P, Stagnaro E, Willett EV, Franceschi S, la Vecchia C, Hughes AM, Cozen W, Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Zheng T. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the InterLymph consortium. Cancer Epidemiol Biomarkers Prev 14:925-933, 2005

Bracci PM, Holly EA. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California. Cancer Causes & Control 16:333-346, 2005

Skibola D, Smith MT, Bracci PM, Hubbard AE, Agana L, Chi S, Holly EA. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. CEBP 14:1251-1256, 2005

Morton LM, Zheng T, Holford TR, Holly EA, Chiu BCH, Constantini AS, Stagnaro E, Willett EV, dal Maso L, Serraino D, Chang ET, Cozen W, Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Hartge P. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis from the InterLymph consortium. Lancet Oncology 6:469-476, 2005

Eberle CA, Bracci PM, Holly EA. Anthropometric factors and pancreatic cancer in the San Francisco Bay Area. Cancer Causes and Control 16:1235-1244, 2005

Chan JM,Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. Cancer Epi Biomarkers & Prevention 14:2093-2097, 2005

Skibola CF, Bracci PM, Paynter RA, Forrest MS, Agana L, Woodage T, Guegler K, Smith MT, Holly EA. Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk. CEBP 14:2391-2401, 2005

Valery PC, Holly EA, Sleigh AC, Williams G, Kreiger N, Bain C. Parental occupation and Ewing's sarcoma: Pooled and meta analysis. Int J Cancer 115:799-806, 2005

Karagas M, Zens MS, Stukel T, Swerdlow, Rosso S, Osterlind A, Mack T, Kirkpatrick C, Holly EA, Green A, Gallagher R, Elwood M, Armstrong B. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes and Control 17:11-19, 2006

Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willettt E, De Sanjose S, Cocco P, Berndt SI, Brennan P Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta B, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager-Jeffery MY, Chanock S, Nieters A. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma:Report from InterLymph Consortium. Lan Onc 7:27-38, 2006

Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 15:630-638, 2006

Duell EJ, Casella DP, Burk RD, Kelsey KT, Holly EA. Inflammation, genetic polymorphisms in pro-inflammatory genes TNF-A, Rantes, and CCR5 and risk of pancreatic adenocarcinoma. Cancer Epidemiology Biomarkers and Prevention 15:726-731, 2006

Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study. Cancer Causes and Control 17:403-409, 2006

Fears TR, Guerry DP, Pfeiffer RP, Sagebiel RW, Elder DE, Halpern A, Holly EA, Hartge P, Tucker MA. Identifying individuals at high risk of melanoma: A practical predictor of absolute risk. J Clin Oncology 24:1-8, 2006

Forrest MS, Skibola CS, lightfoot TJ, Bracci PM, Willett EV, Smith MT, Holly EA, Roman E. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematology 134:180-183, 2006

Flick ED, Bracci PB, Chan KA, Holly EA. Nonsteroidal anti-inflammatory drug use and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiology 164:497-504, 2006

Bracci PB, Dalvi TB, Holly EA. Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 15:1287-1294, 2006

Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 15:1458-1463, 2006

2/20/07

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.